Wolfe Research Initiates Coverage of Neurocrine Biosciences (NBIX) with Outperform Recommendation
Fintel reports that on February 24, 2026, Wolfe Research initiated coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a Outperform recommendation. Analyst…